Angiotensin-Converting Enzyme DD Polymorphism Is Associated With Poor Coronary Collateral Circulation in Patients With Coronary Artery Disease

被引:0
|
作者
Ceyhan, Koksal [1 ]
Kadi, Hasan [1 ]
Celik, Atac [1 ]
Burucu, Turgay [1 ]
Koc, Fatih [1 ]
Sogut, Erkan [2 ]
Sahin, Semsettin [2 ]
Onalan, Orhan [1 ]
机构
[1] Gaziosmanpasa Univ, Fac Med, Dept Cardiol, Tokat, Turkey
[2] Gaziosmanpasa Univ, Fac Med, Dept Biochem, Tokat, Turkey
关键词
collateral circulation; angiotensin-converting enzyme; gene polymorphism; coronary artery disease; ENDOTHELIAL GROWTH-FACTOR; ACUTE MYOCARDIAL-INFARCTION; PLASMA ACE LEVELS; ACTIVITY IN-VIVO; GENE POLYMORPHISM; NITRIC-OXIDE; INSERTION/DELETION POLYMORPHISM; VESSEL DEVELOPMENT; DEPENDENT VASODILATION; DELETION POLYMORPHISM;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Although association between angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism and cardiovascular diseases was reported by many studies, the relation between ACE I/D polymorphism and coronary collateral circulation (CCC) has not been studied yet. The aim of the present study was to investigate a possible relationship between ACE I/D polymorphism and CCC. Methods: Patients who were subjected to coronary angiography in the 2006 to 2009 period and had at least a completely occluded major artery were included in this study. To classify collateral circulation, we used the Rentrop classification. Patients were classified as having poor CCC (Rentrop grades 0 to 1) or good CCC (Rentrop grades 2 to 3). Gene polymorphism was detected through the detailed melting curve analysis of polymerase chain reaction products after amplification using realtime polymerase chain reaction method and LightCycler 1.5 apparatus. Results: We prospectively studied 113 patients who had at least 1 totally occluded major epicardial coronary artery. Forty-seven patients had poor CCC and 67 patients had good CCC. There were no differences among groups in age, sex, risk factors, lipid profile, uses of cardiovascular drugs, and number of diseased vessels. Plasma ACE levels were significantly higher in poor CCC group (P < 0.001). The frequency of DD polymorphism was higher in the poor CCC group (P < 0.001). In allele frequency, we found that the frequency of the D allele was higher in poor CCC group than in the good CCC group (95% confidence interval [CI], 2.16-7.38; P < 0.001). Multiple regression analysis with CCC development as the dependent variable revealed that the presence of total occlusion of the left circumflex artery (95% CI, 1.29-6.6; P = 0.001), ACE DD genotype (95% CI, 2.55-12.79; P = 0.001), presence of diabetes (95% CI, 1.03-3.16; P = 0.005), and pulse pressure (95% CI, 1.04Y1.56; P = 0.045) were independent determinants of poor coronary collateral development. Conclusions: This study showed that ACE DD polymorphism is associated with poor CCC. Poor collateral circulation in patients carrying the D allele may be associated with endothelial dysfunction and elevated blood ACE levels in these patients.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 50 条
  • [31] Polymorphism of the Angiotensin-Converting Enzyme Gene in Patients with Coronary Heart Disease from the Moscow Population
    M. I. Shadrina
    P. A. Slominskii
    O. V. Miloserdova
    N. V. Perova
    S. A. Limborskaya
    Russian Journal of Genetics, 2001, 37 : 432 - 435
  • [32] Genotype distribution of angiotensin-converting enzyme polymorphism in Australian healthy and coronary populations and relevance to myocardial infarction and coronary artery disease
    Wang, XL
    McCredie, RM
    Wilcken, DEL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (01) : 115 - 119
  • [33] Angiotensin-converting enzyme inhibitor therapy for coronary artery disease and diabetes Mellitus
    McConnell, Karen J.
    Zadvorny, Emily B.
    Denham, Anne M.
    Kasten, Sheila L.
    Hutka, Kara A.
    Koetting, Cedar R.
    Merenich, John A.
    AMERICAN JOURNAL OF MANAGED CARE, 2007, 13 (10): : 560 - 566
  • [34] Mildly Decreased Glomerular Filtration Rate Is Associated With Poor Coronary Collateral Circulation in Patients With Coronary Artery Disease
    Kadi, Hasan
    Ceyhan, Koksal
    Sogut, Erkan
    Koc, Fatih
    Celik, Atac
    Onalan, Orhan
    Sahin, Semsettin
    CLINICAL CARDIOLOGY, 2011, 34 (10) : 617 - 621
  • [35] Angiotensin-converting enzyme inhibitor therapy in patients non-obstructive coronary artery disease
    Cenko, E.
    Manfrini, O.
    Morell, C.
    Das, R.
    Barth, J. H.
    Hall, A. S.
    Gale, C. P.
    Bugiardini, R.
    EUROPEAN HEART JOURNAL, 2013, 34 : 416 - 416
  • [36] Angiotensin converting enzyme gene polymorphism in coronary artery disease: The Indian scenario
    Joseph, A
    Nair, KG
    Ashavaid, TF
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1998, 36 (08) : 621 - 624
  • [37] Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease
    Peterson, JG
    Topol, EJ
    Sapp, SK
    Young, JB
    Lincoff, AM
    Lauer, MS
    AMERICAN JOURNAL OF MEDICINE, 2000, 109 (05): : 371 - 377
  • [38] A DELETION POLYMORPHISM IN THE ANGIOTENSIN-CONVERTING ENZYME GENE IS NOT ASSOCIATED WITH CORONARY HEART-DISEASE IN AN AUSTRIAN POPULATION
    FRIEDL, W
    KREMPLER, F
    PAULWEBER, B
    PICHLER, M
    SANDHOFER, F
    ATHEROSCLEROSIS, 1995, 112 (02) : 137 - 143
  • [39] Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease
    Winkelmann, BR
    Nauck, M
    Klein, B
    Russ, AP
    Bohm, BO
    Siekmeier, R
    Ihnken, K
    Verho, M
    Gross, W
    Marz, W
    ANNALS OF INTERNAL MEDICINE, 1996, 125 (01) : 19 - +
  • [40] Angiotensin-converting enzyme gene polymorphism is not associated with coronary atherosclerosis and myocardial infarction in a sample of Italian patients
    Arca, M
    Pannitten, G
    Campagna, F
    Candeloro, A
    Montali, A
    Cantini, R
    Seccareccia, F
    Campa, PP
    Marino, B
    Ricci, G
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1998, 28 (06) : 485 - 490